The management of elderly patients with myeloproliferative disorders.
Tura
S
S
Institute of Hematology L. e A. Seràgnoli, University of Bologna.
D000328:Adult; D000367:Age Factors; D000368:Aged; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000627:therapeutic use; D002908:Chronic Disease; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000628:therapy; D055728:Primary Myelofibrosis / Q000628:therapy; D013920:Thrombocythemia, Essential / Q000188:drug therapy
D010975:Platelet Aggregation Inhibitors; D002066:Busulfan; D006918:Hydroxyurea